INVIVOKINES
Live / Applied — Second extension granted (statement of use) (as of 25 Nov 2025)
What this means for you
Not registered yet, but its 29 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98380457
- Mark type
- Stylized text
- Filed
- 29 Jan 2024
- Published for opposition
- 01 Oct 2024
- Attorney of record
- Benjamin D. Taggart
Goods and services
- Class 001 — Chemicals: Biochemical proteins for scientific, pre-clinical, and clinical research; Biochemical proteins for use in translational in vivo research; Biochemical proteins for use in immunotherapeutic research; Biochemical proteins for use in medical research; Bioreagents for scientific, pre-clinical, and clinical research; Bioreagents for use in translational in vivo research; Bioreagents for use in immunotherapeutic research; Bioreagents for use in medical research
Owner
- Adipogen Life Sciences, Inc., San Diego, CA, US
- Adipogen Life Sciences, Inc., San Diego, CA, US
Prosecution history
- 26 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Nov 2025 — SOU EXTENSION 2 GRANTED
- 25 Nov 2025 — SOU EXTENSION 2 FILED
- 25 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2025 — SOU EXTENSION 1 GRANTED
- 26 May 2025 — SOU EXTENSION 1 FILED
- 08 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Jun 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 03 Jun 2025 — NOTICE OF REVIVAL - E-MAILED
- 03 Jun 2025 — PETITION TO REVIVE-GRANTED
- 03 Jun 2025 — TEAS PETITION TO REVIVE RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION